‘Speed‐ageing’ of human skin in serum‐free organ culture ex vivo: An instructive novel assay for preclinical human skin ageing research demonstrates senolytic effects of caffeine and 2,5‐dimethylpyrazine

Abstract

Preclinical human skin ageing research has been limited by the paucity of instructive and clinically relevant models. In this pilot study, we report that healthy human skin of different age groups undergoes extremely accelerated ageing within only 3 days, if organ‐cultured in a defined serum‐free medium. Quantitative (immuno‐)histomorphometry documented this unexpected ex vivo phenotype on the basis of ageing‐associated biomarkers: the epidermis showed significantly reduced rete ridges and keratinocyte proliferation, sirtuin‐1, MTCO1 and collagen 17a1 protein levels; this contrasted with significantly increased expression of the DNA‐damage marker, γH2A.X. In the dermis, collagen 1 and 3 and hyaluronic acid content were significantly reduced compared to Day 0 skin. qRT‐PCR of whole skin RNA extracts also showed up‐regulated mRNA levels of several (inflamm‐) ageing biomarkers (MMP‐1, ‐2, ‐3, ‐9; IL6, IL8, CXCL10 and CDKN1). Caffeine, a methylxanthine with recognized anti‐ageing properties, counteracted the dermal collagen 1 and 3 reduction, the epidermal accumulation of γH2A.X, and the up‐regulation of CXCL10, IL6, IL8, MMP2 and CDKN1. Finally, we present novel anti‐ageing effects of topical 2,5‐dimethylpyrazine, a natural pheromone TRPM5 ion channel activator. Thus, this instructive, clinically relevant “speed‐ageing” assay provides a simple, but powerful new research tool for dissecting skin ageing and rejuvenation, and is well‐suited to identify novel anti‐ageing actives directly in the human target organ.